J&J Shares Rise on Deal for $9 Billion Settlement
J&J shares climbed after announcing a $9 billion agreement with thousands of plaintiffs over accusations its baby powder and other talc products caused cancer.
J&J shares climbed after announcing a $9 billion agreement with thousands of plaintiffs over accusations its baby powder and other talc products caused cancer.
